Comprehensive Analysis of Medical Cannabis Establishment Ineligibility for Mississippi Research and Development Tax Credits

Medical cannabis establishment ineligibility is the statutory prohibition preventing any business licensed under the Mississippi Medical Cannabis Act from claiming state-level tax incentives, specifically the Research and Development Skills Tax Credit. This legal barrier ensures that while cannabis operations are permitted for therapeutic use, they are excluded from economic subsidies reserved for traditional scientific and technical sectors.1

Statutory Foundations and Legislative Intent

The concept of ineligibility for medical cannabis establishments must be understood as a deliberate policy decision by the Mississippi Legislature to bifurcate the state’s economic incentive landscape. When Senate Bill 2095, known as the Mississippi Medical Cannabis Act, was signed into law on February 2, 2022, it did more than just authorize the medical use of cannabis; it established a parallel tax and regulatory regime that explicitly limits the participation of cannabis businesses in existing state-sponsored growth programs.2 The core of this ineligibility is found in the amendments to Mississippi Code Annotated Section 57-73-21, which serves as the bedrock for various jobs and investment-based tax credits.1

The legislative intent behind these exclusions appears to be a compromise between the legalization of a federally controlled substance and the preservation of “pure” technical incentives for industries such as aerospace, traditional pharmaceuticals, and agricultural research.5 By defining a “medical cannabis establishment” broadly, the legislature ensures that any entity touching the plant—from the point of cultivation to the point of retail sale—is cordoned off from the Research and Development Skills Tax Credit.1 This creates a unique paradox for the burgeoning industry: while a “cannabis research facility” is a recognized and licensed license type under the Act, it is statutorily barred from the very R&D tax credits that its name implies it should receive.1

The Research and Development Skills Tax Credit Framework

To grasp the magnitude of the ineligibility, one must examine the specific credit from which these businesses are barred. The Research and Development Skills Tax Credit, codified under Miss. Code Ann. § 27-7-22.15, is designed to incentivize the hiring of high-skill workers.5 Unlike the federal R&D tax credit, which is primarily spending-based, the Mississippi state credit is employment-based, rewarding businesses for creating positions that require advanced scientific or technical knowledge.5

The credit provides a significant financial incentive of $1,000 per net full-time employee, per year, for a five-year period.5 For a position to qualify, it must meet several rigorous criteria established by the Mississippi Department of Revenue (MDOR) and the Mississippi Development Authority (MDA). First, the position must require a minimum of a bachelor’s degree in a scientific or technical field of study from an accredited four-year college or university.5 Second, the employee must be employed in their specific area of expertise. Third, the compensation for the role must be at a “professional level,” which the MDOR interprets as being commensurate with the market rate for scientific and technical professionals in the region.5

These credits are nonrefundable but offer a carryforward period of five years. Furthermore, they can be used in conjunction with Jobs Tax Credits, though the total combination of such credits cannot offset more than 50 percent of a business’s state income tax liability in a single tax year.5 For traditional tech firms, this credit serves as a critical mechanism for lowering the cost of high-level labor. For medical cannabis establishments, the exclusion represents a direct increase in the cost of conducting high-level scientific work within the state.1

Defining the Ineligible Entities

The scope of ineligibility is determined by the legal definition of a “medical cannabis establishment” as provided in the Mississippi Medical Cannabis Act and adopted by the Department of Revenue in Title 35 of the Mississippi Administrative Code.8 The law casts a wide net, ensuring that no facet of the industry can bypass the exclusion through creative entity structuring or narrowly defined operational roles.7

Classification and Regulatory Authority

The regulatory environment is split between the Mississippi Department of Health (MDOH) and the Mississippi Department of Revenue (MDOR). While the MDOH handles the majority of licensing for plant-touching activities, the MDOR is the primary agency responsible for the oversight of dispensaries and the collection of all industry-related taxes.11

Regardless of whether an entity is a Tier 1 micro-cultivator with a canopy space of less than 1,000 square feet or a large-scale Tier 6 cultivator with over 100,000 square feet, the status as a “medical cannabis establishment” remains the single disqualifying factor for the R&D Skills Tax Credit.1 The administrative regulations further clarify that “cannabis products” include anything infused with THC or CBD, such as topical products, oils, and beverages, meaning that even secondary manufacturers are captured under the ineligibility clause.7

The Research Facility Paradox

The most striking aspect of the ineligibility rule is its application to licensed “cannabis research facilities.” Under Section 1.1.8 of the local ordinances and the state Act, these facilities are explicitly licensed to “research cannabis, develop best practices for specific medical conditions, [and] develop medicines”.9 These activities are, by any standard scientific or federal tax definition, the epitome of research and development.15

However, the Department of Revenue’s guidance and the statutory language of § 57-73-21(2)-(6) make no exception for research-only entities.1 The law states that the “Department of Revenue shall adjust the credit allowed each year… [but] medical cannabis establishments as defined in the Mississippi Medical Cannabis Act shall not be eligible for the tax credit authorized in this subsection”.1 This creates a situation where a chemist at a pharmaceutical firm researching synthetic cannabinoids can generate a $1,000 credit for their employer, while a chemist at a Mississippi-licensed cannabis research facility performing identical laboratory work is ineligible for the same credit.1

Revenue Office Guidance and Enforcement Mechanisms

The Mississippi Department of Revenue has established a robust administrative framework to enforce ineligibility and ensure that cannabis-related tax revenue is tracked separately from other business taxes. This enforcement is achieved through a combination of mandatory North American Industry Classification System (NAICS) codes, specific tax permit requirements, and the use of the statewide “seed-to-sale” tracking system.17

Mandatory NAICS Code Mapping

The Department of Revenue requires every license applicant to obtain a specific tax permit prior to receiving their cannabis license. During this application process via the Taxpayer Access Point (TAP), entities must use designated NAICS codes that allow the department to flag them as medical cannabis establishments.18 This digital tagging is the primary mechanism by which the department prevents the R&D Skills Tax Credit from being claimed on annual income tax returns.

When a business files its annual Mississippi tax return (e.g., Form 84-100 for Pass-Through Entities or Form 83-100 for Corporations), it must list any tax credits on the Tax Credit Summary Schedule (Form 80-401).20 If a business with a cannabis-related NAICS code attempts to claim credit code “15” (the designation for the R&D Skills Tax Credit), the MDOR’s internal systems are programmed to deny the claim based on the statutory exclusion.1

Administrative Bulletins and Technical Notices

The MDOR has issued specific “Notices to Taxpayers” clarifying the impact of 2022 legislation. For instance, the instructions for Pass-Through Entities (PTE) explicitly state that Senate Bill 2773 and Senate Bill 2095 amended the code to exclude any medical cannabis establishment from being eligible for credits related to national or regional headquarters relocation and R&D activities.20

Furthermore, the MDOR provides ongoing guidance on the specific taxes that do apply to these establishments. Cultivators are subject to a 5 percent excise tax on the first sale or transfer of cannabis flower or trim.17 This excise tax applies even when the transfer is to a related entity with common ownership, in which case the tax is calculated based on a “fair market value” (FMV) established by the department.22 The department recalculates these FMV rates twice per year (January 1 and July 1), and these values are mandatory for tax reporting.22

The Convergence of State and Federal Tax Conflict

The ineligibility for state R&D credits must be viewed through the lens of the massive divergence between federal and state tax treatment for cannabis. At the federal level, Internal Revenue Code (IRC) Section 280E remains the dominant hurdle, prohibiting businesses “trafficking” in Schedule I or II controlled substances from deducting any ordinary or necessary business expenses.24 Under 280E, cannabis businesses can only deduct their Cost of Goods Sold (COGS). This results in effective federal tax rates that can reach 70 to 80 percent, as wages, rent, and utility costs are not deductible.25

Mississippi’s Decoupling from IRC 280E

In a significant departure from the federal government’s restrictive stance, Mississippi has codified a “safe harbor” for state-level income tax deductions. Mississippi Code Section 41-137-51 states that “notwithstanding any federal tax law to the contrary,” medical cannabis establishments may deduct all ordinary and necessary expenses paid or incurred during the taxable year.10 This means that while a Mississippi cultivator cannot claim the $1,000 R&D Skills credit, they can deduct the full salary of the botanist or chemist as a standard business expense on their state return.27

This creates a complex tax planning environment where:

1. Federal Level: The business is heavily taxed, loses all R&D credits, and cannot deduct technical salaries (unless they can be characterized as COGS).16
2. State Level: The business is allowed to deduct technical salaries as ordinary expenses, but is strictly prohibited from claiming the targeted $1,000 R&D Skills Tax Credit.1

The Role of House Bill 1733

Further complicating the R&D landscape is Mississippi’s recent passage of House Bill 1733, which allows businesses to elect to fully deduct research or experimental (R&E) expenditures in the year they are incurred.23 This bill was a response to federal changes in the Tax Cuts and Jobs Act (TCJA) that began requiring the amortization of R&D costs over five years. While HB 1733 provides a significant benefit to traditional businesses by allowing for immediate expensing, its application to cannabis establishments is nuanced. Because the cannabis establishments are already granted full deduction rights for “ordinary and necessary” expenses under § 41-137-51, the immediate expensing of R&D under HB 1733 is essentially absorbed into their general state-level deduction rights, providing a less dramatic benefit than it does for traditional firms who were previously struggling with amortization.23

Quantitative Analysis and Economic Implications

The financial weight of ineligibility can be seen in the rapid growth of the Mississippi medical cannabis market. As the industry scales, the “lost value” of the R&D Skills Tax Credit becomes more significant, representing a missed opportunity for the state to subsidize the technical evolution of the sector.

Market Growth and Revenue Statistics

As of August 2025, the Mississippi medical cannabis program reached over 60,000 active cardholders, a substantial increase from the 42,600 patients recorded in August 2024.30 This growth drives a direct increase in employment across the specialized establishments.

Data synthesized from the 2024 Medical Cannabis Program Annual Report.32

In 2024 alone, the program generated approximately $7.8 million in combined excise and sales tax revenue.32 This revenue flows into the state’s General Fund, but none of it is currently “rebated” through R&D or jobs-based incentives to the businesses that generate it.32

The Cost of Ineligibility: A Hypothetical Calculation

Consider a mid-sized cannabis testing laboratory in Mississippi. To maintain its license, it must employ highly qualified staff to run mass spectrometry and liquid chromatography tests.7

• Total Scientific Staff: 12 (all with bachelor’s degrees in Chemistry or Biology).
• Traditional R&D Credit Eligibility: If this were a traditional environmental lab, it would qualify for $1,000 per employee per year for 5 years.5
• Lost Credit Value: $12,000 per year / $60,000 over five years.
• Result: Because the lab holds a “Cannabis Testing Facility” license, it is disqualified.1 The $60,000 in tax savings that would normally offset its state income tax liability is lost, effectively acting as an additional “regulatory tax” on scientific excellence within the cannabis industry.

Practical Examples and Industry Case Studies

To further clarify how the MDOR guidance applies to the law, we can look at comparative scenarios involving businesses that operate on the periphery of the cannabis industry.

Example 1: The Extraction Equipment Manufacturer

A Mississippi-based engineering firm specializes in designing high-pressure CO2 extraction equipment. While their equipment is sold primarily to cannabis processing facilities, the engineering firm itself does not hold a cannabis establishment license from the MDOH or MDOR. They hire three mechanical engineers to develop a new, more efficient extraction valve.

• Outcome: Because the firm is primarily engaged in “manufacturing” and does not meet the definition of a “medical cannabis establishment,” it is eligible for the R&D Skills Tax Credit.1 The fact that their customers are cannabis businesses does not trigger ineligibility for the manufacturer.

Example 2: The Vertically Integrated Cultivator

“Delta Greens, LLC” is a vertically integrated medical cannabis company that holds licenses for cultivation and processing. They employ a full-time PhD-level botanist to cross-breed strains for higher CBD yield.

• Outcome: Delta Greens is a “medical cannabis establishment” as defined by the Act.7 Despite the botanist’s advanced degree and the innovative nature of the work, Delta Greens is ineligible for the R&D Skills Tax Credit under § 57-73-21.1 They must treat the botanist’s salary as a standard deduction under § 41-137-51 rather than as a source of tax credits.27

Example 3: The Third-Party Software Developer

A Jackson-based software startup develops a proprietary inventory tracking system specifically for Mississippi dispensaries to integrate with the state’s seed-to-sale system. They hire four software developers with Computer Science degrees.

• Outcome: If the startup is not licensed as a cannabis establishment, it remains eligible for the R&D Skills Tax Credit.5 The ineligibility is license-dependent, not industry-dependent. This creates a strategic advantage for service providers who remain unlicensed while serving the cannabis sector.

Compliance and Audit Risks

The Mississippi Department of Revenue and the Department of Health maintain a rigorous audit cycle to ensure that medical cannabis establishments are adhering to all tax and tracking requirements.17 For businesses navigating the ineligibility rules, several high-risk areas exist.

Misclassification of NAICS Codes

Attempting to use a non-cannabis NAICS code (such as “General Agriculture” or “Medical Laboratory”) to claim the R&D Skills Tax Credit is a significant audit trigger. The MDOR cross-references TAP registrations with the MDOH license database.12 A mismatch between the reported NAICS code and the actual business activity can lead to the retroactive denial of credits, the imposition of interest and penalties, and even the potential revocation of the business license.17

Seed-to-Sale Data Discrepancies

Mississippi requires the use of a statewide tracking system (Metrc) for all inventory movements.8 The MDOR uses this data to verify excise tax payments. If a cultivator transfers flower to a related processor and reports a value lower than the MDOR’s published fair market value for that period, the department will flag the return for a manual audit.22

Common Ownership and Fair Market Value

One of the most complex areas of guidance involves common ownership. When a cultivation facility and a processing facility or dispensary share a common owner, the 5 percent excise tax must be calculated using the FMV set by the department.22

Fair Market Value Adjustments (Historical Example):

• July 2022 – Dec 2022: $3,200 per lb (Flower) / $640 per lb (Trim)
• Jan 2024 – June 2024: $1,428 per lb (Flower) / $164 per lb (Trim)
• July 2025 – Dec 2025 (Projected): $1,965 per lb (Flower) / $81 per lb (Trim)

Source: MDOR Technical Notices.22

Establishments must ensure their internal accounting reflects these biannual changes. Ineligibility for the R&D credit means these firms have a thinner margin for error; they cannot rely on tax credits to “make up” for overpaid excise taxes resulting from valuation errors.1

Conclusion: Strategic Outlook for the Mississippi Cannabis Sector

The state of medical cannabis establishment ineligibility in Mississippi represents a mature, albeit restrictive, regulatory compromise. By providing a clear statutory bar in Sections 27-7-22.15 and 57-73-21, the state has provided a predictable—if unfavorable—roadmap for business owners.1 The “two-line meaning” remains the guiding principle: the industry is legally authorized but economically excluded from the state’s premier technical workforce incentives.

The long-term outlook for this policy will likely depend on federal action. If the U.S. Drug Enforcement Administration (DEA) successfully moves cannabis from Schedule I to Schedule III, the federal barriers of IRC 280E will likely vanish.16 In such a scenario, Mississippi’s existing “safe harbor” for state deductions will become less of a unique benefit and more of a baseline.27 This might prompt the state legislature to revisit the ineligibility of cannabis establishments for the R&D Skills Tax Credit to ensure that Mississippi remains competitive with other states that may begin to offer more aggressive incentives once federal prohibition ends.

For now, the most successful Mississippi medical cannabis establishments will be those that accept the ineligibility as a cost of entry, focusing instead on the robust state-level deductions allowed under § 41-137-51 and ensuring perfect compliance with the MDOR’s excise and FMV mandates.22 By leveraging the technical talents of their workforce while managing the tax burden through traditional deduction paths, these businesses can still thrive in one of the most rapidly expanding medical cannabis markets in the United States.30

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/